Skip to main content
MBI logo

MBI — Investor Relations & Filings

Ticker · 1783 ISIN · TW0001783009 TW Manufacturing
Open in API
Filings indexed 1,694 across all filing types
Latest filing 2024-06-13 Board/Management Inform…
Country TW Taiwan
Listing TW 1783

About MBI

www.mbi.com.tw

Maxigen Biotech Inc. (MBI) is a medical device manufacturer specializing in the research, development, and production of biopolymer-based solutions, primarily focusing on collagen matrix and hyaluronic acid technologies. The company provides a comprehensive range of medical devices across multiple clinical disciplines, including orthopedics, aesthetics, ophthalmology, and wound care. Key products include hyaluronic acid intra-articular injections, dermal fillers, ophthalmic viscoelastics, collagen wound dressings, dental membranes, and synthetic bone grafts. In addition to its proprietary brands, MBI offers global OEM/ODM and customization services. The company adheres to international quality standards, holding certifications such as CE, FDA, NMPA, and MDSAP. MBI leverages its expertise in biopolymer science to deliver innovative medical and skincare products to international markets.

Recent filings

Filing Released Lang Actions
公告本公司審計委員會委員異動
Board/Management Information Classification · 100% confidence The document is a company announcement regarding changes in the Audit Committee members, specifying dates, names, and reasons for the changes. It does not contain financial data, audit reports, or detailed management discussion. It is an announcement of board/committee member changes, fitting the category of Board/Management Information (MANG). The document length is short and focused solely on personnel changes in the board-related committee.
2024-06-13 Chinese
公告本公司董事會選任董事長
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the appointment of a chairman by the company's board of directors. It includes details such as the date of the board resolution, names of the outgoing and incoming chairman, reasons for the change, and effective date. There is no financial data, no mention of a report or financial results, and the content focuses solely on management changes. This fits the definition of 'Board/Management Information' (MANG). The document length is short and it is not an announcement of a report publication but a direct disclosure of management change.
2024-06-13 Chinese
公告本公司2024年股東常會通過解除新任董事及其代表人 競業禁止之限制案
Board/Management Information Classification · 95% confidence The document is a regulatory announcement from a listed company (1783 和康生) regarding a shareholder meeting resolution passed on 2024/06/13. The content details the approval to lift non-competition restrictions on newly appointed directors and their representatives, including names, roles, and related business activities. It is a formal disclosure of a board/management-related decision rather than a financial report or earnings release. The document length is short (1416 characters) and it does not contain financial statements or detailed financial data. It is not an announcement of voting results but a management-related announcement about board members' permissions and restrictions. Therefore, the most appropriate classification is Board/Management Information (MANG).
2024-06-13 Chinese
公告本公司2024年股東常會全面改選董事及獨立董事
Board/Management Information Classification · 100% confidence The document is a company announcement regarding the comprehensive re-election of directors and independent directors at the 2024 Annual General Meeting (股東常會全面改選董事及獨立董事). It lists old and new directors, their titles, resumes, shareholdings, and effective dates. There is no financial data or report content, only information about changes in board members. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short (2244 characters) and is not a report or presentation but a formal announcement of board changes.
2024-06-13 Chinese
公告本公司2024年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement from a listed company (1783 和康生) regarding the important resolutions made at its 2024 Annual General Meeting (股東常會). It includes details such as the date of the AGM, profit distribution, amendments to the company charter, approval of the business report and financial statements for 2023, election of directors, and other related matters. The content is focused on the outcomes of the AGM rather than the full report itself. The document length is short (851 characters) and it serves as an official announcement of voting results and decisions made at the AGM. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-06-13 Chinese
113年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in shareholdings by insiders, including directors, managers, and related parties. It includes data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of this being a report or announcement of a report, nor is it a certification or legal proceeding. The document fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data on insider shareholdings.
2024-06-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.